Induction of Acute Gastritis and Epithelial Apoptosis by Helicobacter pylori Lipopolysaccharide

References

• Hunt RH, Muhamed AH. The current role of H. pylori eradication in clinical practice. Scand J Gastroenterol 1995; 30: 47–52, Suppl 208
   Web of Science ®Google Scholar
• Marshall BJ. Helicohacter pylori. Am J Gastroenterol 1994; 89: S116–28
   Google Scholar
• Slomiany BL, Murty VLN, Piotrowski J, Slomiany A. Gastroprotective agents in mucosal defense against H. pylori. Gen Pharmacol 1994; 25: 833–41
   PubMedGoogle Scholar
• Rune SJ. History of Helicobacter infection. Scand J Gastroenterol 1996; 31: 2–4, Suppl 214
   Web of Science ®Google Scholar
• Axon ATR. Eradication of Helicobacter pylori. Scand J Gastroenterol 1996; 31: 47–53, Suppl 214
   Web of Science ®Google Scholar
• Stolte M, Edit S. Helicobacter pylori and the evolution of gastritis. Scand J Gastroenterol 1996; 31: 13–6, Suppl 214
   Web of Science ®Google Scholar
• Slomiany BL, Piotrowski J, Samanta A, Van Horn K, Murty VLN, Slomiany A. Campylobacter pylori colonization factor shows specificity for lactosylceramide sulfate and GM3-ganglioside. Biochem Int 1989; 19: 929–36
   PubMedGoogle Scholar
• Slomiany A, Piotrowski J, Slomiany BL. Sucraltate counteracts the inhibition of gastric mucosal mucin receptor by H. pylori lipopolysaccharide. Scand J Gastroenterol 1995; 30: 77–83, Suppl 210
   Web of Science ®Google Scholar
• Slomiany BL, Slomiany A. Mucus and gastric mucosal protection. The stomach, W Domschke, SJ Konturek. Springer-Verlag, Berlin 1993; 116–43
   Google Scholar
• Piotrowski J, Majka J, Slomiany A, Slomiany BL. Helicobacter pylori lipopolysaccharide inhibition of gastric mucosal somatostatin receptor. Biochem Mol Biol Int 1995; 36: 491–8
   PubMedGoogle Scholar
• Harris PR, Mobley LT, Perez-Perez GI, Blaser MJ, Smith PD. Helicobacter pylori urcase is a potent stimulus of mononuclear phagocyte activation and inflammatory cytokine production. Gastroenterology 1996; 111: 419–25
   PubMed Web of Science ®Google Scholar
• Moss SF, Calam J, Agarawal B, Wang S, Holt PR. Induction of gastric epithelial apoplosis by Helicobacter pylori. Gut 1996; 38: 498–501
   PubMed Web of Science ®Google Scholar
• Peek RM, Moss SF, Tham KT, Perez-Perez GI, Miller GG, Holt PR. Infection with H. pylori CagA strains dissociates gastric epithelial proliferation from apoptosis. Gastroenterology 1996; 110: A575
   Google Scholar
• Sherr CJ. GI phase progression: cycling on cue. Cell 1994; 79: 561–5
   Google Scholar
• Loyer P, Carlou S, Glaise D, Bilodeau M, Baffet G, Guguen-Gullouzo C. Growth factor dependence of progression through GI and S phases of adult rat hepatocytes in vitro. J Biol Chem 1996; 271: 11484–92
   PubMed Web of Science ®Google Scholar
• Thomson CB. Apoptosis in the pathogenesis and treatment of disease. Science 1995; 267: 1456–62
   PubMed Web of Science ®Google Scholar
• Jones NI, Yeger H, Cutz E, Sherman PM. Helicobacter pylori induces apoptosis of gastric antral epithelial cells in vivo. Gastroenterology 1996; 110: A933
   Google Scholar
• Piotrowski J, Skrodzka D, Slomiany A, Slomiany BL. Helicobacter pylori lipopolysaccharide inductuces gastric epithelial apoptosis. Biochem Mol Biol Int 1996; 40: 597–602
   PubMedGoogle Scholar
• Goodwin CS, Kirsch DR, Chilvers T, Peters M, Collins D, Sly L. Transfer of C. pylori and C. mustelae to Helicobacter gen. nov. as pylori comb. nov. and H. mustelae comb, nov., respectively. Int J Syst Bacteriol 1989; 39: 397–405
   Google Scholar
• Galanos C, Luderitz O, Westphal O. A new method for the extraction of R. lipopolysaccharide. Eur J Biochem 1969; 9: 245–9
   PubMedGoogle Scholar
• Slomiany BL, Piotrowski J, Murty VLN, Slomiany A. Mechanism of ebrotidine protection against gastric mucosal injury induced by ethanol. Gen Pharmacol 1992; 23: 719–27
   PubMedGoogle Scholar
• Rauws EAJ, Langenberg W, Houthoff HJ, Zanen MC, Tytgat GNJ. Campylobacter pylori-associated chronic active antral gastritis. A prospective study of its prevalence and the effect of antibacterial and antiulcer treatment. Gastroenterology 1988; 94: 33–40
   PubMedGoogle Scholar
• Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 1992; 119: 493–501
   PubMed Web of Science ®Google Scholar
• Stolte M, Edit S. Chronic erosions of the antral mucosa; a sequela of Helicobacter pylori-induced gastritis. Z Gastroentorol 1992; 30: 846–50
   PubMedGoogle Scholar
• Tomkins LS, Falkow S. The new path to prevent ulcers. Science 1995; 267: 1621–2
   PubMedGoogle Scholar
• Harris PR, Mobley HLT, Perez-Perez GI, Blaser MJ, Smith PD. Helicobacter pylori urease is a potent stimulus of mononuclear phagocyte activation and inflammatory cytokine production. Gastroenterology 1996; 111: 419–25
   PubMed Web of Science ®Google Scholar
• Crabtree JE. Immune and inflammatory responses to Helicobacter pylori infection. Scand J Gastroenterol 1996; 31: 3–10, Suppl 215
   Web of Science ®Google Scholar
• Moran AP. Pathogenic properties of Helicobacter pylori. Scand J Gastroenterol 1996; 31: 22–31, Suppl 215
   Web of Science ®Google Scholar
• Slomiany BL, Piotrowski J, Rajiah G, Slomiany A. Inhibition of gastric mucosal laminin receptor by H. pylori lipopolysaccharide: effect of nitecapone. Gen Pharmacol 1991; 22: 1063–9
   PubMedGoogle Scholar
• Frisch SM, Francis H. Disruption of epithelial cell-matrix interactions induces apoptosis. J Cell Biol 1994; 124: 619–26
   PubMed Web of Science ®Google Scholar
• Ruoslahti E, Reed JC. Anchorage dependence, integrins, and apoptosis. Cell 1994; 77: 477–8
   PubMed Web of Science ®Google Scholar
• Juliano RL, Haskill S. Signal transduction from the extracellular matrix. J Cell Biol 1993; 120: 577–85
   PubMed Web of Science ®Google Scholar